Hoth Therapeutics HOTH
$ 0.85
-5.45%
Quarterly report 2024-Q3
added 11-12-2024
Hoth Therapeutics Balance Sheet 2011-2024 | HOTH
Annual Balance Sheet Hoth Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-9.24 M | - | - | -2.63 M | -1.69 M | -283 K | -1.23 M | - | - | - | - | - | - |
Long Term Debt |
26.3 K | - | - | - | - | - | - | - | - | - | - | - | - |
Long Term Debt Current |
28.8 K | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 285 K | - | - | - | - | - | - | - | - | - |
Total Current Liabilities |
679 K | 1.39 M | 868 K | 312 K | 440 K | 349 K | - | - | - | - | - | - | - |
Total Liabilities |
705 K | 1.64 M | 1.1 M | 597 K | 440 K | 349 K | 49.5 K | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-52.9 M | -45.1 M | -33.7 M | -19.4 M | -12.2 M | -4.51 M | -2.02 M | - | - | - | - | - | - |
Total Assets |
9.52 M | 6.76 M | 11 M | 5.24 M | 2.84 M | 504 K | 1.23 M | - | - | - | - | - | - |
Cash and Cash Equivalents |
9.29 M | 6.43 M | 8.54 M | 2.63 M | 1.69 M | 283 K | - | - | - | - | - | - | - |
Book Value |
8.82 M | 5.12 M | 9.88 M | 4.65 M | 2.4 M | 155 K | 1.18 M | - | - | - | - | - | - |
Total Shareholders Equity |
8.82 M | 5.12 M | 9.88 M | 4.65 M | 2.4 M | 155 K | 1.18 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Balance Sheet Hoth Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
2.71 K | 11 K | 18.9 K | 26.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
2.71 K | 11 K | 18.9 K | 26.3 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
813 K | 692 K | 659 K | 705 K | 1.58 M | 1.97 M | 1.6 M | 1.64 M | 1.28 M | 1.03 M | 1.06 M | 1.1 M | 1.84 M | 1.45 M | 1.04 M | 597 K | 597 K | 597 K | 597 K | 440 K | 440 K | 440 K | 440 K | 349 K | 349 K | 349 K | 349 K | 49.5 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-58.7 M | -56.6 M | -55 M | -52.9 M | -51.2 M | -49.2 M | -47.3 M | -45.1 M | -41.6 M | -39 M | -36.3 M | -33.7 M | -30.2 M | -27 M | -23.7 M | -19.4 M | -19.4 M | -19.4 M | -19.4 M | -12.2 M | -12.2 M | -12.2 M | -12.2 M | -4.51 M | -4.51 M | -4.51 M | -4.51 M | -2.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
8.31 M | 10 M | 8.49 M | 9.52 M | 12.1 M | 11.9 M | 13.5 M | 6.76 M | 9.89 M | 12.3 M | 8.95 M | 11 M | 15.2 M | 18 M | 21 M | 5.24 M | 5.24 M | 5.24 M | 5.24 M | 2.84 M | 2.84 M | 2.84 M | 2.84 M | 504 K | 504 K | 504 K | 504 K | 1.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
8 M | 9.65 M | 7.56 M | 9.29 M | 11.8 M | 11.5 M | 13 M | 6.43 M | 8.94 M | 11.3 M | 6.38 M | 8.54 M | 12.4 M | 15.9 M | 19.3 M | 2.63 M | 2.63 M | 2.63 M | 2.63 M | 1.69 M | 1.69 M | 1.69 M | 1.69 M | 283 K | 283 K | 283 K | 283 K | 1.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Book Value |
7.49 M | 9.34 M | 7.83 M | 8.82 M | 10.5 M | 9.95 M | 11.9 M | 5.12 M | 8.61 M | 11.2 M | 7.88 M | 9.88 M | 13.3 M | 16.6 M | 19.9 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 155 K | 155 K | 155 K | 155 K | 1.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
7.49 M | 9.34 M | 7.83 M | 8.82 M | 10.5 M | 9.95 M | 11.9 M | 5.12 M | 8.61 M | 11.2 M | 7.88 M | 9.88 M | 13.3 M | 16.6 M | 19.9 M | 4.65 M | 4.65 M | 4.65 M | 4.65 M | 2.4 M | 2.4 M | 2.4 M | 2.4 M | 155 K | 155 K | 155 K | 155 K | 1.18 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency